UDITAS
Live / Registered — Registered (as of 25 Feb 2025)
What this means for you
Registered since 25 Feb 2025. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 97515642
- Registration number
- 7706997
- Mark type
- Stylized text
- Filed
- 22 Jul 2022
- Published for opposition
- 22 Aug 2023
- Registered
- 25 Feb 2025
- Attorney of record
- Sarah Anne Keefe
Goods and services
- Class 042 — Scientific and technological services: Medical laboratory services; Scientific laboratory services; Pharmaceutical research; Medical and scientific research in the fields of genome editing, gene editing, genome engineering, gene modulation, transcriptional regulation, transcriptional modulation, genetic diseases, gene therapy and cell therapy; Providing medical research and scientific research information in the fields of genome editing, gene editing, genome engineering, gene modulation, transcriptional regulation, transcriptional modulation, genetic diseases, gene therapy and cell therapy
Owner
- Editas Medicine, Inc., Cambridge, MA, US
- Editas Medicine, Inc., Cambridge, MA, US
- Editas Medicine, Inc., Cambridge, MA, US
Prosecution history
- 25 Feb 2025 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 25 Feb 2025 — REGISTERED-PRINCIPAL REGISTER
- 05 Feb 2025 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 05 Feb 2025 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 04 Jan 2025 — STATEMENT OF USE PROCESSING COMPLETE
- 17 Oct 2024 — USE AMENDMENT FILED
- 04 Jan 2025 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 17 Oct 2024 — TEAS STATEMENT OF USE RECEIVED
- 09 Apr 2024 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 08 Apr 2024 — SOU EXTENSION 1 GRANTED
- 08 Apr 2024 — SOU EXTENSION 1 FILED
- 08 Apr 2024 — SOU TEAS EXTENSION RECEIVED
- 17 Oct 2023 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 22 Aug 2023 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 22 Aug 2023 — PUBLISHED FOR OPPOSITION